FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound represented by formula (I), its isomer or its pharmaceutically acceptable salt, where the carbon atom with the sign "*" may be a chiral carbon atom present in the form of one (R) or (S) enantiomer or in the form enriched with one enantiomer; X is CH; R1 is H; R2 is C1-6-alkyl. The invention also relates to a pharmaceutical composition for treating or preventing the development of a disease treatable by TLR8 agonism based on a compound of formula (I).
EFFECT: obtaining a new compound and a pharmaceutical composition based on it, which can be used in medicine for the treatment of a viral infection caused by the hepatitis B virus.
12 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVE OF PYRIDOPYRIMIDINE, METHOD FOR PRODUCTION THEREOF AND APPLICATION THEREOF IN MEDICINE | 2019 |
|
RU2778524C2 |
| SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS | 2010 |
|
RU2580320C2 |
| IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS TOLL-LIKE RECEPTOR AGONISTS | 2020 |
|
RU2785124C1 |
| PYRAZOLO-HETEROARYL DERIVATIVE, METHOD FOR ITS PREPARATION AND MEDICAL USE | 2017 |
|
RU2748833C2 |
| COMPOUND WHICH IS PRO-DRUG OF LANOSTEROL, AS WELL AS METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720677C1 |
| BORATE DERIVATIVE OF AZETIDINE | 2019 |
|
RU2802287C2 |
| THIOPHENE COMPOUND, ITS PRODUCTION METHOD AND ITS PHARMACEUTICAL APPLICATION | 2017 |
|
RU2709473C1 |
| THIAZOLACTAM COMPOUNDS AS ERK INHIBITORS AND THEIR APPLICATIONS | 2020 |
|
RU2805569C1 |
| ANALOGUE OF INDOLOHEPTAMILOXIME AS A PARP INHIBITOR | 2020 |
|
RU2811039C2 |
| FLUOROVINYLBENZAMIDE COMPOUND AS A PD-L1 IMMUNOMODULATOR | 2020 |
|
RU2789450C1 |
